A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype.

Ann Thorac Med 2017 Apr-Jun;12(2):101-106

Department of Medicine, King Saud University, Riyadh, Saudi Arabia.

Background: Osteoporosis, the most common extra-pulmonary complication of chronic obstructive pulmonary disease (COPD), may be related to general causes or COPD-specific causes such as low forced expiratory volume in 1 s (FEV1) and hypoxia. A few studies reported that emphysema is an independent risk factor for osteoporosis. However, other workers considered the association to be confounded by low FEV1 and low body mass index (BMI) which cluster with emphysema.

Aims: To study the association between osteoporosis and emphysema in a model that includes these potentially confounding factors.

Methods: We studied prospectively 52 COPD patients with both high resolution computed tomography and carbon monoxide diffusion coefficient as diagnostic markers of emphysema. Dual-energy X-ray absorptiometry was used to measure the bone mass density (BMD) of lumbar vertebrae and neck of the femur. Vertebral fractures were evaluated using the Genant semiquantitative score. Multiple linear regression analysis was used to identify the following independent variables: age, BMI, FEV1% predicted, PaO, emphysema score, C-reactive protein (CRP), and dyspnea score as related to BMD. ≤ 0.05 was considered statistically significant.

Results: There was no significant difference in the serum Vitamin D levels, vertebral fracture score, or BMD between the emphysematous and nonemphysematous patients. Multivariate analysis showed that (in a model including age, BMI, FEV1, PaO, emphysema score, CRP, and dyspnea score) only reduced BMI, FEV1, and PaO were independent risk factors for low BMD.

Conclusions: The emphysematous phenotype is not a risk factor for osteoporosis independently of BMI, FEV1, and PaO.
PDF Download - Full Text Link
( Please be advised that this article is hosted on an external website not affiliated with PubFacts.com)
Source Status
http://dx.doi.org/10.4103/atm.ATM_357_16DOI ListingPossible
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399683PMCFound
May 2017
2 Reads

Similar Publications

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.

Am J Med 1996 Sep;101(3):262-9

Department of Medicine, Columbia-Presbyterian Medical Center, New York, New York 10032, USA.

Purpose: Fractures, a common complication of cardiac and liver transplantation, have not been reported in association with lung transplantation. However, many patients with end-stage pulmonary disease have multiple risk factors for osteoporosis, and several studies have suggested that osteoporosis before transplantation may increase the risk of fracture after transplantation. Therefore, we evaluated a group of patients with end-stage pulmonary disease who were awaiting lung transplantation to determine the prevalence of osteoporosis. Read More

View Article
September 1996

Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease.

COPD 2012 Aug 11;9(4):332-7. Epub 2012 Apr 11.

Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Bone mineral density (BMD) alone does not reliably predict osteoporotic fractures. The Fracture Risk Assessment Tool (FRAX) was developed to estimate the risk of fracture in the general population. This study was designed to identify predictors of osteoporosis and vertebral fractures in patients presenting with chronic obstructive pulmonary disease (COPD). Read More

View Article
August 2012

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis.

Respir Res 2011 Dec 16;12:157. Epub 2011 Dec 16.

Department of Respiratory Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Background: Osteoporosis is one of the systemic features of COPD. A correlation between the emphysema phenotype of COPD and reduced bone mineral density (BMD) is suggested by some studies, however, the mechanisms underlying this relationship are unclear. Experimental studies indicate that IL-1β, IL-6 and TNF-α may play important roles in the etiology of both osteoporosis and emphysema. Read More

View Article
December 2011

Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study.

Bone 2012 Jun 9;50(6):1234-9. Epub 2012 Mar 9.

Department of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.

The prevalence of osteoporosis is high in chronic obstructive pulmonary disease (COPD) patients. The gold standard for the diagnosis of osteoporosis is bone mineral density (BMD) measurements as assessed by dual energy absorptiometry (DXA) scanning as well as vertebral fractures as assessed by instant vertebral assessment (IVA). The aim of this study was to compare COPD GOLD II patients (that is, patients with moderate COPD, stage II, according to the GOLD classification) with osteoporosis (cases) to COPD GOLD II patients without osteoporosis (controls) to identify risk factors for osteoporosis. Read More

View Article
June 2012